Several factors contribute to the delay in cancer discoveries. Scientific complexity is a major factor. Cancer is not a single disease but a collection of related diseases, each with its own unique genetic and molecular profile. This complexity makes it challenging to identify universal treatments. Furthermore, research funding is often limited, causing delays in essential studies. Regulatory hurdles and the need for extensive clinical trials to ensure patient safety also contribute to these delays.
